Christopher Kuhlman, PhD, DABT
Dr. Christopher Kuhlman is a Project Toxicologist at the Center for Toxicology and Environmental Health, L.L.C. (CTEH®). Dr. Kuhlman’s background includes a B.S. in Biochemistry from The University of California, Los Angeles (UCLA), with coursework focusing on physiology, chemistry, atmospheric and oceanic science, and microbiology. Upon graduation from UCLA, he worked at Bachem Americas, Inc. in Torrance, California as a Research and Development Chemist. In a good laboratory practice (GLP) environment, he was involved in the synthesis and purification of active pharmaceutical ingredients. His work experience triggered an interest in the mechanism of action and toxicity of pharmaceuticals; which is why he moved to pursue a Ph.D. in the field of Pharmacology and Toxicology from The University of Arizona. His graduate research investigated renal- and hematopoietic tissue proteins targeted by the reactive electrophilic metabolites of benzene and endogenous lipid electrophiles formed as a consequence of elevated oxidative stress. Upon extracting the bone marrow of rodents treated with benzene metabolites, he used state-of-the-art proteomics technologies to identify amino acid modifications on proteins associated with genomic stability, protein folding, and metabolism.
As a Project Toxicologist at CTEH®, Dr. Kuhlman specializes in toxicology, risk assessment, toxicity evaluations, and emergency response toxicology. He is a responding toxicologist in the CTEH® Toxicology Emergency Response Program (TERP®). Dr. Kuhlman participates in a variety of projects, including evaluating the relationship between chemical exposure and disease, formulation of emergency response guides, and involvement in environmental contamination and toxic tort litigation.
Ph.D., Pharmacology and Toxicology, University of Arizona, Tucson, AZ
B.S., Biochemistry, University of California, Los Angeles, CA
Past or Current Professional Affiliations
- Society of Toxicology
- American Society for Pharmacology and Experimental Therapeutics
- American Industrial Hygiene Association